1 - 2 toradh á dtaispeáint as 2 toradh san iomlán ar an gcuardach 'Zhifeng Li (1776799)', am iarratais: 0.01s Beachtaigh na torthaí
  1. 1
    Supplementary file 2_Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial.docx

    Supplementary file 2_Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in Ch... de réir Xiaohu Jin (9618675)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe: “…Zhifeng Li (1776799)…”
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Supplementary file 1_Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in China: based on the SONIA trial.docx

    Supplementary file 1_Cost-effectiveness analysis of first-line versus second-line use of CDK4/6 inhibitors combined with endocrine therapy in advanced HR+/HER2- breast cancer in Ch... de réir Xiaohu Jin (9618675)

    Foilsithe / Cruthaithe 2025
    Rannpháirtithe: “…Zhifeng Li (1776799)…”
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: